Merck & Co Inc - Common Stock (MRK)

Historical Holders from Q1 2014 to Q1 2025

Symbol: MRK on NYSE
CUSIP: 58933Y105
Type / Class: Equity / Common Stock
Shares outstanding: 2.53B
All holders as of December 31, 2024: Q4 2024
Shares, excl. options: 1.97B
Holdings value: $196B
% of all portfolios: 0.178%
Grand Portfolio weight change: +0.008%
Number of holders: 3505
Number of buys: 1382
Number of sells: -1750
Average Value change %: -0.07%
Average buys %: +0.014%
Average sells %: -0.084%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Merck & Co Inc - Common Stock (MRK)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD GROUP INC	10.02%		$23.6B		253M		The Vanguard Group	Feb 28, 2025

Institutional Holders of Merck & Co Inc - Common Stock (MRK)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q1	43.8M	$3.93B	-$256M	117K		$89.76	655
2024 Q4	1.97B	$196B	+$4.6B	1.34B	1.53B	$99.48	3,505
2024 Q3	1.91B	$217B	-$5.51B	1.57B	1.73B	$113.56	3,429
2024 Q2	1.95B	$242B	+$5.25B	1.31B	1.64B	$123.80	3,470
2024 Q1	1.89B	$249B	-$1.74B	1.97B	2.31B	$131.95	3,483
2023 Q4	1.91B	$209B	+$4.43B	1.44B	1.62B	$109.02	3,326
2023 Q3	1.84B	$190B	-$1.45B	1.13B	1.45B	$102.95	3,132
2023 Q2	1.88B	$217B	-$3.47B	1.46B	1.64B	$115.39	3,177
2023 Q1	1.9B	$203B	+$1.65B	1.18B	1.41B	$106.39	3,094
2022 Q4	1.89B	$210B	+$3.42B	1.82B	1.96B	$110.95	3,148
2022 Q3	1.87B	$162B	+$779M	1.38B	1.82B	$86.12	2,919
2022 Q2	1.65B	$150B	+$3.01B	1.46B	1.86B	$91.17	2,943
2022 Q1	1.82B	$149B	-$444M	1.37B	1.92B	$82.05	2,883
2021 Q4	1.82B	$139B	+$180M	1.74B	2.36B	$76.64	2,839
2021 Q3	1.83B	$138B	-$898M	1.47B	2.36B	$75.11	2,594
2021 Q2	1.84B	$143B	-$391M	1.06B	1.28B	$77.77	2,616
2021 Q1	1.84B	$142B	-$951M	1.08B	1.17B	$77.09	2,633
2020 Q4	1.62B	$132B	-$299M	1B	1.36B	$81.80	2,640
2020 Q3	1.87B	$155B	-$982M	1.19B	1.57B	$82.95	2,508
2020 Q2	1.88B	$145B	-$663M	871M	1.11B	$77.33	2,447
2020 Q1	1.88B	$145B	-$1.72B	1.12B	1.13B	$76.94	2,424
2019 Q4	1.9B	$173B	+$7.23M	1.66B	1.42B	$90.95	2,480
2019 Q3	1.92B	$161B	-$1.28B	1.38B	1.2B	$84.18	2,263
2019 Q2	1.93B	$162B	+$2.78B	1.09B	1.06B	$83.85	2,246
2019 Q1	1.94B	$162B	-$1.58B	1.31B	1.42B	$83.17	2,234
2018 Q4	1.97B	$150B	-$1.18B	1.38B	1.51B	$76.41	2,197
2018 Q3	1.97B	$140B	+$3.6B	935M	1.11B	$70.94	2,005
2018 Q2	1.94B	$118B	-$2.07B	923M	942M	$60.70	1,973
2018 Q1	1.99B	$109B	-$902M	1.07B	1.24B	$54.47	1,945
2017 Q4	2.01B	$113B	-$1.11B	1.07B	866M	$56.27	1,959
2017 Q3	2.03B	$130B	+$1.16B	819M	882M	$64.03	1,880
2017 Q2	2.03B	$130B	-$1.3B	925M	1.25B	$64.09	1,878
2017 Q1	2.03B	$129B	+$11.2B	848M	1.03B	$63.54	1,888
2016 Q4	2.04B	$120B	-$1.97B	1.22B	831M	$58.87	1,867
2016 Q3	2.06B	$128B	+$1.03B	1.23B	900M	$62.41	1,763
2016 Q2	2.04B	$118B	+$35.4M	864M	674M	$57.61	1,708
2016 Q1	2.04B	$108B	-$647M	646M	571M	$52.91	1,689
2015 Q4	2.05B	$108B	-$2.1B	809M	836M	$52.82	1,704
2015 Q3	2.09B	$103B	-$220M	978M	867M	$49.39	1,615
2015 Q2	2.06B	$117B	-$177M	814M	763M	$56.93	1,673
2015 Q1	2.1B	$121B	-$453M	709M	883M	$57.48	1,660
2014 Q4	2.11B	$120B	-$479M	1.17B	748M	$56.79	1,663
2014 Q3	2.11B	$125B	-$1.86B	847M	868M	$59.28	1,566
2014 Q2	2.14B	$124B	-$1.51B	694M	811M	$57.85	1,563
2014 Q1	2.17B	$123B	+$3.68B	627M	927M	$56.77	1,545